Stock Analysis

Is KuibyshevAzot (MCX:KAZT) Using Too Much Debt?

MISX:KAZT
Source: Shutterstock

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with many other companies Public Joint Stock Company KuibyshevAzot (MCX:KAZT) makes use of debt. But should shareholders be worried about its use of debt?

What Risk Does Debt Bring?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. When we think about a company's use of debt, we first look at cash and debt together.

Check out our latest analysis for KuibyshevAzot

How Much Debt Does KuibyshevAzot Carry?

As you can see below, KuibyshevAzot had ₽24.5b of debt, at December 2020, which is about the same as the year before. You can click the chart for greater detail. On the flip side, it has ₽3.63b in cash leading to net debt of about ₽20.9b.

debt-equity-history-analysis
MISX:KAZT Debt to Equity History May 3rd 2021

A Look At KuibyshevAzot's Liabilities

We can see from the most recent balance sheet that KuibyshevAzot had liabilities of ₽10.8b falling due within a year, and liabilities of ₽26.0b due beyond that. Offsetting these obligations, it had cash of ₽3.63b as well as receivables valued at ₽4.60b due within 12 months. So it has liabilities totalling ₽28.6b more than its cash and near-term receivables, combined.

This deficit is considerable relative to its market capitalization of ₽42.4b, so it does suggest shareholders should keep an eye on KuibyshevAzot's use of debt. Should its lenders demand that it shore up the balance sheet, shareholders would likely face severe dilution.

In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). The advantage of this approach is that we take into account both the absolute quantum of debt (with net debt to EBITDA) and the actual interest expenses associated with that debt (with its interest cover ratio).

While KuibyshevAzot has a quite reasonable net debt to EBITDA multiple of 2.2, its interest cover seems weak, at 1.3. This does have us wondering if the company pays high interest because it is considered risky. Either way there's no doubt the stock is using meaningful leverage. Also relevant is that KuibyshevAzot has grown its EBIT by a very respectable 27% in the last year, thus enhancing its ability to pay down debt. When analysing debt levels, the balance sheet is the obvious place to start. But you can't view debt in total isolation; since KuibyshevAzot will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. So we always check how much of that EBIT is translated into free cash flow. In the last three years, KuibyshevAzot's free cash flow amounted to 33% of its EBIT, less than we'd expect. That's not great, when it comes to paying down debt.

Our View

KuibyshevAzot's struggle to cover its interest expense with its EBIT had us second guessing its balance sheet strength, but the other data-points we considered were relatively redeeming. In particular, its EBIT growth rate was re-invigorating. Looking at all the angles mentioned above, it does seem to us that KuibyshevAzot is a somewhat risky investment as a result of its debt. That's not necessarily a bad thing, since leverage can boost returns on equity, but it is something to be aware of. There's no doubt that we learn most about debt from the balance sheet. But ultimately, every company can contain risks that exist outside of the balance sheet. We've identified 4 warning signs with KuibyshevAzot (at least 2 which are significant) , and understanding them should be part of your investment process.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

If you’re looking to trade KuibyshevAzot, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


Valuation is complex, but we're here to simplify it.

Discover if KuibyshevAzot might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About MISX:KAZT

KuibyshevAzot

Public Joint Stock Company KuibyshevAzot, together with its subsidiaries, engages in the manufacture, distribution, and sale of various chemicals in Russia, Asia, rest of Europe, and internationally.

Outstanding track record with flawless balance sheet.